{"id":7003,"date":"2022-04-28T20:49:44","date_gmt":"2022-04-28T20:49:44","guid":{"rendered":"https:\/\/www.tun.com\/courses\/2019\/12\/23\/preparing-prep-for-providers-and-patients\/"},"modified":"2022-04-28T20:49:44","modified_gmt":"2022-04-28T20:49:44","slug":"preparing-prep-for-providers-and-patients","status":"publish","type":"post","link":"https:\/\/www.tun.com\/courses\/preparing-prep-for-providers-and-patients\/johns-hopkins-university\/","title":{"rendered":"PrEParing: PrEP for Providers and Patients"},"content":{"rendered":"
\n
\n
\n

Description<\/h2>\n

Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine\/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing. <\/p>\n

This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in the field. A first of its kind learning opportunity, both providers and patients learn from the same experts through content that meets the needs of both audiences, while facilitating the opportunity for a shared community space. <\/p>\n

Lessons for healthcare workers provide background on foundational and cutting-edge research and PrEP guidelines, how to initiate a PrEP program, clinical management and providing culturally sensitive sexual health and primary care to diverse communities. <\/p>\n

Lessons for PrEP enthusiasts, PrEP users or the PrEP curious provide information regarding who can benefit from PrEP, how to access services, what to expect and how to stick with your PrEP program long-term.<\/p>\n

OBJECTIVES:<\/p>\n

At the conclusion of the session, the participant will be able to:<\/p>\n

1.\tDescribe the differences between foundational PrEP studies and demonstration projects
\n2.\tDescribe the basic pharmacodynamics of tenofovir\/emtricitibine including mechanism of infection prevention and time
\n to protective concentration in mucosal tissues
\n3.\tList recommendations from PrEP for Prevention of HIV Infection in the United States clinical practice guidelines, USPHS
\n and CDC, including initial and ongoing screening and testing
\n4.\tDescribe the need for PrEP as an HIV prevention tool for priority in often stigmatized populations
\n5.\tIndicate the components for integrating PrEP services into clinical practice
\n6.\tOutline guidelines for screening and treatment of sexually transmitted infections
\n7.\tDescribe how to take a thorough sexual history and to engage with clients around sex in an affirming and non-
\n judgmental manner
\n8.\tList the baseline and follow-up laboratory monitoring required
\n9.\tExplain key aspects of patient education for HIV prevention and sexual health
\n10.\tDescribe protocols for ongoing PrEP services and when to discontinue<\/p>\n

FACULTY\/ CREDENTIALS:<\/p>\n

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, Associate Professor
\nJohns Hopkins University School of Nursing<\/p>\n

Chris Beyrer, MD, MPH, Professor
\nJohns Hopkins University Bloomberg School of Public Health<\/p>\n

Yusuf Ariyibi, BA, Disease Intervention Specialist
\nBaltimore City Health Department<\/p>\n

Joyce Jones, MD, MS, Clinical Associate
\nJohns Hopkins University School of Medicine<\/p>\n

Neha Sheth Pandit, PharmD, AAHIVP, BCPS, Associate Professor
\nUniversity of Maryland School of Pharmacy<\/p>\n

Pierre-Cedric Crouch, PhD, ANP-BC, ACRN, Director of Nursing
\nSan Francisco AIDS Foundation<\/p>\n

Renata Arrington Sanders, MD, Assistant Professor
\nJohns Hopkins University School of Medicine<\/p>\n

Jenell Coleman, MD, MPH, Associate Professor
\nJohns Hopkins University School of Medicine<\/p>\n

Michele Decker, ScD, MPH, Associate Professor
\nJohns Hopkins University Bloomberg School of Public Health<\/p>\n

Deborah Dunn, PA-C, MBA, Physician Assistant
\nChase Brexton Health Care<\/p>\n

Jordan White, MS, Desmond Tutu Fellow of Public Health and Human Rights
\nJohns Hopkins University Bloomberg School of Public Health<\/p>\n

Gregory Lucas, MD, PhD, Professor
\nJohns Hopkins University School of Medicine<\/p>\n

Demetre Daskalakis, MD, MPH, Acting Deputy Commissioner, Division of Disease Control, NYC Dept. of Health and Mental Hygiene<\/p>\n

David Dowdy, MD, PhD, Associate Professor
\nJohns Hopkins University Bloomberg School of Public Health<\/p>\n

Jessica LaRicci, PrEP Coordinator
\nJohns Hopkins University School of Nursing<\/p>\n

Susan Tuddenham, MD, MPH, Assistant Professor
\nJohns Hopkins University School of Medicine<\/p>\n

Joseph Cofrancesco, MD, MPH, FACP, Associate Professor of Medicine
\nJohns Hopkins University School of Medicine<\/p>\n

Jill Crank, CRNP, MSN\/MPH, Nurse Practitioner
\nEvergreen Healthcare<\/p>\n

Paul Sacamano, MPH, ANP-BC, ACRN, PrEP Project Lead
\nJohns Hopkins University School of Nursing<\/p>\n

Shima Ge, BS, PrEP Peer Navigator
\nJohns Hopkins University School of Nursing<\/p>\n

ORIGINATION DATE\t October 02, 2017
\nRENEWAL DATE:\t\t\t\t November 30, 2019
\nEXPIRATION DATE:\t\t\t November 30, 2021<\/p>\n

URL: https:\/\/www.coursera.org\/learn\/prep\/<\/p>\n

HARDWARE\/SOFTWARE: Computer Hardware; Internet connection; Browser<\/p>\n

MATERIALS: None<\/p>\n

TARGET AUDIENCE: physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, health education specialists, public health workers, social workers, case managers<\/p>\n

PREREQUISITES: None<\/p>\n

FORMAT: These seminars are enduring video presentations with online discussion forum and resources.<\/p>\n

CONTACT INFORMATION: Office of The REACH Initiative, Johns Hopkins University School of Nursing (888) 788-7737 <\/p>\n

ACCREDITATION STATEMENTS:<\/p>\n

CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Johns Hopkins University School of Nursing. The Centers for Disease Control and Prevention is accredited by the (ACCME\u00ae) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.<\/p>\n

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credits\u2122. <\/p>\n

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.1 CEU’s for this program.<\/p>\n

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and\/or Master Certified Health Education Specialists (MCHES) to receive up to 10.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.<\/p>\n

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.<\/p>\n

This program is a designated event for pharmacists to receive 1.05 CEUs in pharmacy education. The Universal Activity Number is 0387-9999-19-191-H01-P.<\/p>\n

Category: This activity has been designated as Knowledge-Based.<\/p>\n

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP\/CPE Monitor.<\/p>\n

For Certified Public Health Professionals (CPH)
\nThe Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 11 CPH recertification credits for this program.<\/p>\n

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. <\/p>\n

CDC, our planners, our content experts and their spouses\/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Jason Farley and he wishes to disclose that he received grant from Gilead. Planning committee discussed conflict of interest with Dr. Farley to ensure there is no bias.
\nContent will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Arrington Sander\u2019s discussion of PrEP for adolescents, PrEP is not approved for adolescents < 18 years old; and Dr. Tuddenham\u2019s discussion of STI screening, she will be discussing extra genital screening with NAAT currently recommended by CDC.\n\nCDC did not accept commercial support for this continuing education activity.\n\nInstructions for Obtaining Continuing Education (CE)\n\nIn order to receive continuing education (CE) for WD2928- PrEParing: PrEP for Providers and Patients please visit TCEO and follow these 9 Simple Steps before 11\/30\/2021 \n\nComplete the activity\nComplete the Evaluation at https:\/\/tceols.cdc.gov\/\nPass the posttest at 80% at https:\/\/tceols.cdc.gov\/ \nEmail son-reachinititiative@jhu.edu once the above is cpmpleted for CE\n\nFEES: No fees are charged for CDC\u2019s CE activities.<\/p>\n

<\/div>\n

Price: Enroll For Free!<\/h2>\n
<\/div>\n
View Class<\/a><\/div>\n
<\/div>\n
\n
\n

Language:<\/strong> <\/em>English<\/p>\n<\/div>\n

\n

Subtitles<\/strong>: <\/em>English<\/p>\n<\/div>\n<\/div>\n

PrEParing: PrEP for Providers and Patients – Johns Hopkins University<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Description Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine\/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing. This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in the field. A first of […]<\/p>\n","protected":false},"author":1,"featured_media":19396,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[172],"tags":[],"class_list":["post-7003","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-johns-hopkins-university"],"aioseo_notices":[],"uagb_featured_image_src":{"full":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png",378,224,false],"thumbnail":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education-150x150.png",150,150,true],"medium":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education-300x178.png",300,178,true],"medium_large":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png",378,224,false],"large":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png",378,224,false],"1536x1536":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png",378,224,false],"2048x2048":["https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png",378,224,false]},"uagb_author_info":{"display_name":"Axiom Pegasus","author_link":"https:\/\/www.tun.com\/courses\/author\/magic\/"},"uagb_comment_info":0,"uagb_excerpt":"Description Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine\/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing. This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in the field. A first of…","featured_media_src_url":"https:\/\/www.tun.com\/courses\/wp-content\/uploads\/2019\/12\/Johns-Hopkins-Universityonline-education.png","_links":{"self":[{"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/posts\/7003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/comments?post=7003"}],"version-history":[{"count":0,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/posts\/7003\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/media\/19396"}],"wp:attachment":[{"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/media?parent=7003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/categories?post=7003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tun.com\/courses\/wp-json\/wp\/v2\/tags?post=7003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}